BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28288951)

  • 1. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.
    Shah NN; Freeman AF; Su H; Cole K; Parta M; Moutsopoulos NM; Baris S; Karakoc-Aydiner E; Hughes TE; Kong HH; Holland SM; Hickstein DD
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):980-990. PubMed ID: 28288951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency.
    Cuellar-Rodriguez J; Freeman AF; Grossman J; Su H; Parta M; Murdock H; Shah N; Bollard C; Kong HH; Moutsopoulos N; Stone K; Gea-Banacloche J; Holland SM; Hickstein DD
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1037-45. PubMed ID: 25636378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen.
    Parta M; Shah NN; Baird K; Rafei H; Calvo KR; Hughes T; Cole K; Kenyon M; Schuver BB; Cuellar-Rodriguez J; Zerbe CS; Holland SM; Hickstein DD
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1250-1259. PubMed ID: 29412158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
    Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG; Chu JI; Ciocarlie OC; Doğu F; Gaspar HB; Geha RS; Gennery AR; Hauck F; Hawwari A; Hickstein DD; Hoenig M; Ikinciogullari A; Klein C; Kumar A; Ifversen MRS; Matthes S; Metin A; Neven B; Pai SY; Parikh SH; Picard C; Renner ED; Sanal Ö; Schulz AS; Schuster F; Shah NN; Shereck EB; Slatter MA; Su HC; van Montfrans J; Woessmann W; Ziegler JB; Albert MH;
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):848-855. PubMed ID: 30391550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
    Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N
    Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    Sahebi F; Eikema DJ; Koster L; Kroger N; Meijer E; van Doesum JA; Rovira M; Koc Y; Angelucci E; Blaise D; Sammassimo S; McDonald A; Arroyo CH; Sanchez JF; Forcade E; Castagna L; Stölzel F; Sanz J; Tischer J; Ciceri F; Valcarcel D; Proia A; Hayden PJ; Beksac M; Yakoub-Agha I; Schönland S
    Transplant Cell Ther; 2021 Dec; 27(12):999.e1-999.e10. PubMed ID: 34543768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
    Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
    Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
    Freeman AF; Yazigi N; Shah NN; Kleiner DE; Parta M; Atkinson P; Heller T; Holland SM; Kaufman SS; Khan KM; Hickstein DD
    Transplantation; 2019 Oct; 103(10):2144-2149. PubMed ID: 30720689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.
    DeZern AE; Zahurak M; Symons H; Cooke K; Jones RJ; Brodsky RA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):498-504. PubMed ID: 28013015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
    Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
    Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
    Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
    Al-Herz W; Chu JI; van der Spek J; Raghupathy R; Massaad MJ; Keles S; Biggs CM; Cockerton L; Chou J; Dbaibo G; Elisofon SA; Hanna-Wakim R; Kim HB; Lehmann LE; McDonald DR; Notarangelo LD; Veys P; Chatila TA; Geha RS; Gaspar HB; Pai SY
    J Allergy Clin Immunol; 2016 Sep; 138(3):852-859.e3. PubMed ID: 27130861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
    J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors.
    Anurathapan U; Hongeng S; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Charoenkwan P; Jetsrisuparb A; Sanpakit K; Rujkijyanont P; Meekaewkunchorn A; Lektrakul Y; Iamsirirak P; Surapolchai P; Satayasai W; Sirireung S; Sruamsiri R; Wahidiyat PA; Ungkanont A; Issaragrisil S; Andersson BS
    Bone Marrow Transplant; 2016 Jun; 51(6):813-8. PubMed ID: 26878659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial.
    Bolaños-Meade J; Cooke KR; Gamper CJ; Ali SA; Ambinder RF; Borrello IM; Fuchs EJ; Gladstone DE; Gocke CB; Huff CA; Luznik L; Swinnen LJ; Symons HJ; Terezakis SA; Wagner-Johnston N; Jones RJ; Brodsky RA
    Lancet Haematol; 2019 Apr; 6(4):e183-e193. PubMed ID: 30878319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency.
    Freeman AF; Shah NN; Parta M; Su HC; Brofferio A; Gradus-Pizlo I; Butty S; Hughes TE; Kleiner DE; Avila D; Heller T; Kong HH; Holland SM; Hickstein DD
    J Allergy Clin Immunol Pract; 2016; 4(6):1239-1242.e1. PubMed ID: 27641484
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency.
    Nichols-Vinueza DX; Parta M; Shah NN; Cuellar-Rodriguez JM; Bauer TR; West RR; Hsu AP; Calvo KR; Steinberg SM; Notarangelo LD; Holland SM; Hickstein DD
    Br J Haematol; 2022 Jan; 196(1):169-178. PubMed ID: 34580862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
    Duléry R; Bastos J; Paviglianiti A; Malard F; Brissot E; Battipaglia G; Médiavilla C; Giannotti F; Banet A; de Wyngaert ZV; Ledraa T; Belhocine R; Sestili S; Adaeva R; Lapusan S; Isnard F; Legrand O; Vekhoff A; Rubio MT; Ruggeri A; Mohty M
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1407-1415. PubMed ID: 30871978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.
    Yu X; Liu L; Xie Z; Dong C; Zhao L; Zhang J; Gu J; Zhu HH
    Crit Rev Oncol Hematol; 2019 Jan; 133():120-128. PubMed ID: 30661648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.